Summit Therapeutics plc (SMMT) Social Stream



Summit Therapeutics plc (SMMT): $2.07

0.07 (+3.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Summit Therapeutics Inc (SMMT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SMMT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
NA 1 $NA $NA $NA $2.03 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


Over the past 148 days, SMMT's average price target has gone down $0.

Over the past 33 weeks, SMMT's average upside potential has been -34.85%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 3 5 4 4.5 8.00 -43.75%
2021-04-10 2 5 4 4.5 5.63 -20.07%
2021-07-03 2 5 4 4.5 7.75 -41.94%
2021-05-22 2 5 4 4.5 8.46 -46.81%
2021-05-08 2 5 4 4.5 5.82 -22.68%

SMMT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • SMMT has a higher number of analysts covering the stock than nearly none of all US stocks.
  • In terms of how Summit Therapeutics Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than almost 100% of that group.
  • In the context of stocks in the small market cap category, Summit Therapeutics Inc's average analyst price target is greater than nearly none of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Summit Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than nearly none of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Summit Therapeutics Inc are SLS, SLRX, and SLGL.

Is SMMT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.6311 seconds.